SPX3,825.33+39.95 1.06%
DIA310.85+3.03 0.98%
IXIC11,127.85+99.11 0.90%

BRIEF-Apellis And SOBI Report New Data Reinforcing Robust Efficacy And Safety Profile Of EMPAVELI

reuters.com · 06/10/2022 03:09
BRIEF-Apellis And SOBI Report New Data Reinforcing Robust Efficacy And Safety Profile Of EMPAVELI

- Apellis Pharmaceuticals Inc APLS:

  • APELLIS AND SOBI REPORT NEW DATA REINFORCING THE ROBUST EFFICACY AND SAFETY PROFILE OF EMPAVELI® (PEGCETACOPLAN) FOR PNH AT EHA 2022 CONGRESS

Source text for Eikon: ID:nGNX4m0M8Z

Further company coverage: APLS


((Reuters.Briefs@thomsonreuters.com;))